Opendata, web and dolomites

DERMAE

Clinical research for the validation of a non-invasive medical imaging device for dermatological diagnoses

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 DERMAE project word cloud

Explore the words cloud of the DERMAE project. It provides you a very rough idea of what is the project "DERMAE" about.

melanoma    few    issue    patient    damages    entire    deformation    excise    anomaly    diagnostic    micrometers    millions    images    image    instrument    mu    invasive    cancers    dermatological    tumor    detected    skin    medical    microscope    portion    60    excision    imaging    producing    procedure    world    innovative    constitute    cellular    diagnoses    tissues    pathologies    perform    40    biopsy    dermatologist    15    mainly    scarring    deep    visually    resolution    days    histological    healthcare    incurs    slices    diseases    remove    dangerous    pain    misses    patients    tool    biological    dermae    tissue    dyes    announcement    12    dermatology    reoperation    introduce    lesion    time    surgical    minor    solves    performed    surface    cut    optical    situ    structural    treatment    extra    structures    reception    potentially    internal    thickness    awarded    implies    histopathological    sections    criteria    necessitate    stress    dermatologists    consuming    diagnosis    macroscopic    consult    form    technique    revolutionize    color    mm    act    size    benign    biopsies    symptoms    painful    freeze   

Project "DERMAE" data sheet

The following table provides information about the project.

Coordinator
DAMAE MEDICAL 

Organization address
address: BATIMENT 503 - CAMPUS SCIENTIFIQUE D'ORSAY
city: ORSAY
postcode: 91400
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Project website http://damaemedical.fr/w/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-04-01   to  2015-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DAMAE MEDICAL FR (ORSAY) coordinator 50˙000.00

Map

 Project objective

Diagnosis and study of many diseases in dermatology, including cancers, mainly depend on biopsy and histopathological analysis of tissue at the cellular-level using an optical microscope. This medical procedure implies to perform a biopsy, i.e. to excise a portion of tissue, then to freeze and cut the sample into slices of a few micrometers thickness and use specific dyes. This procedure is painful and potentially dangerous for the patient. Moreover it is time-consuming and may introduce structural deformation or damages. Skin diseases like Melanoma are rapidly growing throughout the world. About 12 millions biopsies are performed each year by dermatologists. As a minor surgical act, the biopsy process involves pain, possible scarring, and stress during the 15 days before reception of analyses results. In 60% of the cases, the skin anomaly is benign and do not necessitate further treatment. However, the patients need to consult another time with the dermatologist for the announcement of the results of the biopsy, which incurs extra medical costs and time. Moreover, as symptoms are detected on a macroscopic-level with surface criteria (color, form and size of the lesion), the dermatologist misses over one third of the pathologies. Finally, as the tissue excision is visually performed, 40% of reoperation is necessary to remove the entire tumor. DERMAE is a highly recognized and awarded innovative project that solves this major healthcare issue by developing an innovative instrument capable of producing in situ images of biological tissues similar to histological sections. This non- invasive imaging technique will be able to image in real time the internal structures (up to 1 mm deep) of biological tissues at the cellular level (about 1 μm resolution). This imaging technology will constitute a new diagnostic tool that may revolutionize the medical procedures in dermatological diagnoses.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DERMAE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DERMAE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

TT4CL (2019)

Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Read More  

MISTRAL (2020)

Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination

Read More  

HELP (2019)

Collaboration for innovation: Establishment of a pan-nematode drug development platform

Read More